22.04.2014 Views

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SRA 2013 Annual Meeting <strong>Abstracts</strong><br />

W2-F.2 Paulson, G; Brennan, T*; US Environmental Protection<br />

Agency; paulson.glenn@epa.gov<br />

Developments in Scientific Peer Review at EPA<br />

The EPA has a strong tradition of scientific peer review. In fact,<br />

the agency’s Peer Review Policy notes that “Peer review of all<br />

scientific and technical in<strong>for</strong>mation that is intended to in<strong>for</strong>m or<br />

support agency decisions is encouraged and expected.” This<br />

presentation will cover the tradition of peer review at the<br />

agency as well as a few of the recent developments on peer<br />

review activities. First, the historical context <strong>for</strong> the importance<br />

and practice of peer review at the agency as summarized in the<br />

EPA Peer Review Handbook will be presented. The Agency is<br />

currently in the process of revising the 2006 third edition of the<br />

Handbook. One area of focus <strong>for</strong> this revision is options to<br />

increase agency oversight of implementation of the peer review<br />

policy. In addition, in May of 2013, EPA’s Acting Administrator<br />

announced a new process <strong>for</strong> peer reviews conducted by panels<br />

of experts selected and managed by EPA contractors. Much of<br />

the new process focuses on opportunities <strong>for</strong> public<br />

engagement on the peer review process and conflict of interest<br />

procedures <strong>for</strong> these contractor-led reviews. Finally, the<br />

Science Advisory Board’s (SAB) process of peer review will be<br />

summarized, from panel selection, to access to meeting<br />

materials, to new ef<strong>for</strong>ts by the SAB Staff Office to enhance<br />

public transparency of the work of the SAB.<br />

P.51 Pawlisz, AV; Conestoga-Rovers& Associates;<br />

apawlisz@craworld.com<br />

Hydraulic Fracturing Failure Rates – Key to<br />

Understanding Actual <strong>Risk</strong>s<br />

Extraction of natural gas deposits via hydraulic fracturing<br />

(fracking) has grown at an unprecedented rate in the United<br />

States and worldwide. For various reasons, this method of<br />

natural resource retrieval has met considerable opposition from<br />

the regulatory community and the public. One of the sensitive<br />

issues is the potential <strong>for</strong> adverse impacts to the environment<br />

and human health, particularly relative to groundwater<br />

extraction, drinking water pollution, deep chemical injection,<br />

well failures, blow outs, on-site spills, air emissions, transport<br />

accidents, and noise. This presentation compiles the most<br />

recent data on various incident/accident/spill/release rates<br />

published by the industry, government agencies, and open<br />

literature. Failure data are used to conduct a predictive risk<br />

assessment where the calculated odds ratios are compared to<br />

those <strong>for</strong> conventional hydrocarbon extraction methods. The<br />

overall objective is to provide an insight on how fracking<br />

compares to other drilling and oil/gas operations in terms of the<br />

potential <strong>for</strong> overall environmental impacts.<br />

M4-A.5 Perez, V*; Garry, MR; Alexander, DD; Tsuji, JS;<br />

Exponent; vperez@exponent.com<br />

Noncancer risk assessment of epidemiological studies of<br />

arsenic and cardiovascular disease<br />

The U.S. Environmental Protection Agency is currently revising<br />

their 1988 noncancer and cancer risk assessments <strong>for</strong> inorganic<br />

arsenic. Cardiovascular disease (CVD) is an endpoint with<br />

considerable recent studies supporting derivation of a<br />

non-cancer reference dose (RfD) <strong>for</strong> arsenic. We conducted a<br />

systematic review of the epidemiologic literature through<br />

March 2013 <strong>for</strong> scientific evidence that may support an RfD<br />

specific to CVD. Eleven cohort and case-control studies<br />

(Taiwan, Bangladesh, and China) assessing the effect of water<br />

arsenic at levels

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!